Prepare yourself to be able to diagnose rare tumors in the gynecology and be more effective in the treatments prescribed to your patients, improving their quality of life" 

Urological neoplasms are, in themselves, an uncommon group of tumors. They constitute 11% of those affecting men and 3% of those occurring in women. These tumors may be rare because of their location, such as penile carcinoma, with an incidence of 0.6/100,000 persons/year; or they may be rare because they show an atypical histology in the context of the location in which they occur, for example, neuroendocrine tumors of the prostate. They all have, however, one thing in common: they are orphans. This means that there is little evidence on the best way to treat them. Clinical guidelines rarely allude to these situations and, when they do, they advise inclusion of the patient in a clinical trial. 

On the other hand, rare tumors of gynecologic origin often pose challenges for the specialist, who only deals with them on rare occasions, hence the need to stay up to date and stay familiar with the management of these pathologies. 

Finally, breast cancer is the most frequently diagnosed tumor in women; however, it is important to bear in mind that this breast pathology comprises a very heterogeneous group of pathologies, not all as common as invasive ductal carcinoma or invasive lobular carcinoma, which represent around 80% of breast cancers and, consequently, are not always easy to diagnose, treat or prognosticate. At present, treatment must be individualized, assessing both the clinical stage and the biological characteristics of the tumor, as well as prognostic and predictive factors of response, and, to achieve this, interdisciplinary study and the pooling of continuous advances in research are essential. 

In this program, the experts, all of them referents in each area of knowledge, will develop aspects related to the context of this spectrum of pathologies, will present the clinical and molecular vision of the same, will show their diagnostic and therapeutic approaches, and will explain complementary aspects such as their research and institutional environment or the global reality of the patients who suffer from them. In this way, a global vision is offered, as well as a specific one, of this type of pathologies, with the objective of specializing you for professional success. 

Students will be able to complete the program at their own pace, without being subject to fixed schedules or the travel involved in classroom teaching, so they can combine it with the rest of their daily obligations. 

Learn about the latest developments in this type of pathology and expand your medical knowledge in an understudied area" 

This postgraduate certificate in Infrequent Tumors of the Gynecologic Area. Rare Breast Tumors. Genitourinary Oncology of Rare Tumors contains the most complete and up-to-date scientific program on the market. Its most notable features are:

• Case studies presented by experts in oncology
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional development
• Updates on tumors of the gynecological and genitourinary area
• Practical exercises where self-assessment can be used to improve learning
• Special emphasis on innovative methodologies in the approach to this type of tumors
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

TECH offers you a 100% online program that will allow you to combine your studies with your professional work while increasing your knowledge in this field" 

The teaching staff includes professionals from the Oncology sector, who bring their experience to this educational program, as well as renowned specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive knowledge programmed to learn in real situations. 

This program is designed around Problem-Based Learning, whereby the specialist must try to solve the different professional practice situations that arise throughout the program. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts. 

You will learn more about orphan urological neoplasms from experts, advancing in your academic career"

Thanks to this program, you will know how to recognize rare types of breast cancer, the most specific aspects of its approach and the complexity of its treatment"

The design of this postgraduate certificate in Uncommon Gynecologic Tumors. Rare Breast Tumors. Genitourinary Oncology of Uncommon Tumors will allow the student to delve into a field of medicine that is under constant research due to its rarity. This way, you will update your professional profile and boost your career in a field of study that demands specialists. There, the program has been developed by a team of experts with contents that will enable the future graduate to reach the proposed objectives. However, you will be fully empowered to deal with the latest advances and the newest treatments currently being applied. For this reason, TECH has established a series of general and specific objectives for the satisfaction of future graduates, as follows: 

You will update your knowledge of rare gynecologic cancers with the medical elite" 

General Objectives

• Acquire concepts and knowledge regarding the epidemiology, clinical, diagnosis and treatment of infrequent tumors, agnostic diagnoses and cancers of unknown origin
• Know how to apply the diagnostic algorithms and evaluate the prognosis of this pathology
• Be able to integrate knowledge and face the complexity of formulating clinical and diagnostic judgments based on the available clinical information
• Know how to apply acquired knowledge and problem-solving skills in new or unfamiliar environments within broader (or multidisciplinary) contexts related to the area of study
• Know how to establish complex therapeutic plans in the context of the pathology in question Have a deeper knowledge of specific treatment networks, reference centers, clinical trials
• Incorporate new technologies into daily practice, knowing their advances, limitations and future potential
• Acquire knowledge about molecular biology tools for the study of these tumors
• Have thorough knowledge and use Tumor Registries
• Know and use the face-to-face or virtual Molecular Committees
• Understand fundamental aspects of biobank operation
• Specialize in interprofessional relationship tools for the treatment of orphan, agnostic and cancer of unknown origin and to access expert networks in the different pathology groups
• Know how to apply knowledge to solve clinical and research problems in the area of rare pathology
• Know how to communicate conclusions, knowledge, and supporting arguments to specialized and non-specialized audiences in a clear and unambiguous way
• Acquire the learning skills to enable further studying in a largely self directed or autonomous manner
• Possess and understand knowledge that provides a basis or opportunity to be original in the development and/or application of ideas, often in a research context
• Understand the social responsibility due to rare diseases 

Specific Objectives

• Study orphan urological neoplasms in depth
• Address rare urological pathology in terms of its clinical, diagnostic and therapeutic aspects, with special emphasis on molecular developments in recent years, in which many of these tumors are beginning to be tributary to a molecular approach
• Update knowledge on rare gynecologic cancers
• Recognize the rare types of breast cancer, the more specific aspects of their approach and the complexity of their treatment

Our goal is to achieve academic excellence and help you achieve professional success"